Literature DB >> 9681822

Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues.

H Lee1, N J Maihle.   

Abstract

ErbB-3 is a member of the epidermal growth factor receptor (EGFR/ErbB) family. In addition to the previously reported 6.2 kb full-length and 1.4 kb truncated c-erbB3 transcripts, we have observed a 1.7 kb c-erbB3 human transcript in Northern blots that specifically hybridizes to a probe of the extracellular domain of the receptor. Using 3'-RACE we have isolated four novel c-erbB3 cDNA clones of 1.6, 1.7, 2.1 and 2.3 kb from a human ovarian carcinoma-derived cell line. All four alternate transcripts are synthesized by readthrough of an intron and use of an alternative polyadenylation signal within this intron. Identical c-erbB3 transcripts are expressed in normal human placental tissues. Expression of these alternate transcripts is tissue-specific as indicated by Northern blot and RNase protection analyses. Fibroblasts transfected with expression vectors carrying these alternate c-erbB3 cDNA clones stably express truncated ErbB-3 products. Three of these four cDNA clones express a receptor product that is secreted. Immunoprecipitation analysis of primary cultures of human ovarian carcinomas also demonstrate the expression of a 90 kDa ErbB-3 related protein that is secreted. Furthermore, we demonstrate conservation of the exon-intron junctions between members of the erbB gene family in those regions of the gene encoding the extracellular domain. This gene structure is also conserved in the c-erbB1 homologues of Drosophila and C. elegans. Growth regulatory roles for related truncated ErbB products recently have been reported. It is, therefore, possible that the products of these four alternate c-erbB3 transcripts may also play important growth regulatory roles in normal and transformed cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681822     DOI: 10.1038/sj.onc.1201866

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity.

Authors:  M L Gagnon; D R Bielenberg; Z Gechtman; H Q Miao; S Takashima; S Soker; M Klagsbrun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Soluble HER3 predicts survival in bladder cancer patients.

Authors:  Ashfaque A Memon; Stephen C Gilliver; Michael Borre; Jan Sundquist; Kristina Sundquist; Ebba Nexo; Boe S Sorensen
Journal:  Oncol Lett       Date:  2017-11-22       Impact factor: 2.967

Review 3.  EGFR/HER-targeted therapeutics in ovarian cancer.

Authors:  Jason A Wilken; Tayf Badri; Sarah Cross; Rhoda Raji; Alessandro D Santin; Peter Schwartz; Adam J Branscum; Andre T Baron; Adam I Sakhitab; Nita J Maihle
Journal:  Future Med Chem       Date:  2012-03       Impact factor: 3.808

4.  The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor.

Authors:  J K Doherty; C Bond; A Jardim; J P Adelman; G M Clinton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

5.  Characterization of glycosylation sites of the epidermal growth factor receptor.

Authors:  Yuejun Zhen; Richard M Caprioli; James V Staros
Journal:  Biochemistry       Date:  2003-05-13       Impact factor: 3.162

6.  Identification of potential glycan cancer markers with sialic acid attached to sialic acid and up-regulated fucosylated galactose structures in epidermal growth factor receptor secreted from A431 cell line.

Authors:  Shiaw-Lin Wu; Allen D Taylor; Qiaozhen Lu; Samir M Hanash; Hogune Im; Michael Snyder; William S Hancock
Journal:  Mol Cell Proteomics       Date:  2013-01-31       Impact factor: 5.911

7.  Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion.

Authors:  Michael P Sanderson; Sascha Keller; Angel Alonso; Svenja Riedle; Peter J Dempsey; Peter Altevogt
Journal:  J Cell Biochem       Date:  2008-04-15       Impact factor: 4.429

Review 8.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

9.  3,3'-diindolylmethane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways.

Authors:  Michael Rouse; Roshni Rao; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2014-06-04       Impact factor: 4.030

10.  ErbB expression: the mouse inner ear and maturation of the mitogenic response to heregulin.

Authors:  Clifford R Hume; Mette Kirkegaard; Elizabeth C Oesterle
Journal:  J Assoc Res Otolaryngol       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.